Invesco Ltd. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 161 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,763,436
+45.0%
417,876
+6.5%
0.00%
Q2 2023$1,216,149
+113.7%
392,306
-4.2%
0.00%
Q1 2023$568,998
-30.1%
409,351
+0.1%
0.00%
Q4 2022$813,586
+62.1%
408,837
+64.5%
0.00%
Q3 2022$502,000
-40.5%
248,522
-6.2%
0.00%
Q2 2022$843,000
-3.7%
264,990
+26.2%
0.00%
Q1 2022$875,000
-5.7%
209,933
+8.4%
0.00%
Q4 2021$928,000
-14.5%
193,710
-4.6%
0.00%
Q3 2021$1,086,000
-22.4%
203,119
-25.6%
0.00%
Q2 2021$1,400,000
-5.0%
273,190
+24.8%
0.00%
Q1 2021$1,473,000
+53.3%
218,948
+4.1%
0.00%
Q4 2020$961,000
-4.2%
210,420
-18.6%
0.00%
Q3 2020$1,003,000
-40.7%
258,501
-27.2%
0.00%
-100.0%
Q2 2020$1,690,000
+111.2%
354,983
+54.5%
0.00%
Q1 2020$800,000
+250.9%
229,724
+384.6%
0.00%
Q4 2019$228,000
+56.2%
47,400
-5.8%
0.00%
Q3 2019$146,000
-90.0%
50,306
-75.2%
0.00%
Q2 2019$1,453,000
+96.1%
202,689
+287.7%
0.00%
Q1 2019$741,000
-84.8%
52,283
-85.4%
0.00%
-100.0%
Q4 2018$4,861,000
-56.6%
359,279
-28.8%
0.00%
-50.0%
Q3 2018$11,203,000
+26.5%
504,841
-6.5%
0.00%
+33.3%
Q2 2018$8,859,000539,8360.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders